Low-dose ASA is a mainstay of therapy for patients with high CV risk. A proportion of the patients are also at risk for GI complications. GI events can lead the patients to be non-adherent to their low-dose ASA therapy with consequently severe CV events as a result. This slide presentation takes you through highlights from the literature on this specific patient population.
This slide set provides an overview of GERD, its impact, prevalence, diagnosis and management. It also gives information on GerdQ, the reflux questionnaire that helps in identifying patients with GERD and can be used to monitor treatment. Where applicable, figures have been reproduced with permission from the author and the original publisher.
This slide kit demonstrates the burden of illness from GERD. It clearly shows
that the prevalence is high, the perspective of doctors and patients may
differ, the reflux disease is costly to patients and society etc.
These slides and slide notes provide information on the bacterium Helicobacter
pylori and its role in gastrointestinal diseases, and are available for you to
view or download. We would like to thank the authors and the following journals
for giving their permission to reproduce the figures in these slides: Am J
Gastroenterol; BMJ; Digestion (Karger, Basel); Science Press; Scand J
This slide set outlines the gastroduodenal risks that are associated with
non-steroidal anti-inflammatory drugs (NSAIDs) and is available for you to view
or download. Where applicable, figures have been reproduced with permission
from the author and original publisher.
These slides and accompanying notes provide general information about
dyspepsia, and are available for you to view or download. We would like to
thank the authors and the following journals for giving their permission to
reproduce the figures in these slides: Br J Gen Pract; Gastroenterology; Gut;
Scand J Gastroenterol.
This new slide set provides an overview of the epidemiology of complicated peptic ulcer and peptic ulcer bleeding, the possible factors contributing to the change in incidence in peptic ulcer and some explanation why the incidence of peptic ulcer bleed hasn't decreased significantly in the past decades.